Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POLY-ACS: Polypill Strategy for ACS Patients Undergoing PCI
NCT05514938Phase 2Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Nov 2022
- Primary completion
- May 2025
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin + atorvastatin + hydrochlorothiazide + enalapril in acute coronary syndrome (ACS), sponsored by UT Southwestern Medical Center. Started Nov 2022; status: completed.
02
Drugs
aspirin + atorvastatin + hydrochlorothiazide + enalapril
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT05514938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05514938.